Stratified analysis in randomized trials with noncompliance

Biometrics

Volumn 61, Issue 3, 2005, Pages 816-823

  Matsui, Shigeyuki ^a  

^a KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

Author keywords

Causal effect; Efficiency; Noncompliance; Randomization; Stratified analysis

Indexed keywords

RANDOM PROCESSES;

CAUSAL EFFECT; CONFIDENCE LIMIT; ESTIMATING FUNCTIONS; INSTRUMENTAL VARIABLES; NATURAL EXTENSION; NONCOMPLIANCE; OPTIMAL WEIGHT; RANDOMISATION; RANDOMIZED TRIAL; STRATIFIED ANALYSIS;

EFFICIENCY;

STATISTICAL ANALYSIS;

ARTICLE; INSTRUMENTATION; RANDOMIZATION; STATISTICAL ANALYSIS; STATISTICAL DISTRIBUTION; STATISTICAL PARAMETERS; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TREATMENT REFUSAL;

CHOLESTEROL;

CHOLESTEROL; CORONARY DISEASE; DATA INTERPRETATION, STATISTICAL; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; SMOKING CESSATION; TREATMENT REFUSAL;

EID: 27744450834     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1541-0420.2005.00339.x     Document Type: Article

References (23)

1. Angrist, J. D., Imbens, G. W., and Rubin, D. B. (1996). Identification of causal effects using instrumental variables. Journal of the American Statistical Association 91, 444-455.
2. 2 test. Biometrics 10, 417-451.
3. Cuzick, J., Edward, R., and Segnan, N. (1997). Adjusting for non-compliance and contamination in randomized clinical trials. Statistics in Medicine 16, 1017-1029.
4. Fisher, L. D., Dixon, D. O., Herson, J., Frankowski, R., Hearron, M., and Peace, K. E. (1990). Intention to treat in clinical trials. In Statistical Issues in Drug Research and Development, K. E. Peace (ed), 331-350. New York: Marcel Dekker.
5. Fisher, R. A. (1935). The Design of Experiments. London: Oliver and Boyd.
6. Godambe, V. P. (1960). An optimum property of regular maximum likelihood estimation. Annals of Mathematical Statistics 31, 1208-1211.
7. Greenland, S. (2000). An introduction to instrumental variables for epidemiologists. International Journal of Epidemiology 29, 722-729.
8. Greenland, S. and Robins, J. M. (1985). Estimation of a common effect parameter from sparse follow-up data. Biometrics 41, 55-68.
9. Hauck, W. W. (1979). The large-sample variance of the Mantel-Haenszel estimator of a common odds ratio. Biometrics 35, 817-819.
10. Lee, Y., Ellenberg, J., Hirtz, D., and Nelson, K. (1991). Analysis of clinical trials by treatment actually received: Is it really an option? Statistics in Medicine 10, 1595-1605.
11. Mantel, N. and Haenszel, W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 22, 719-748.
12. Mark, S. D. and Robins, J. M. (1993). A method for the analysis of randomized trials with compliance information: An application to the multiple risk factor intervention trial. Controlled Clinical Trials 14, 79-97.
13. Multiple Risk Factor Intervention Trial Research Group. (1982). Multiple risk factor intervention trial: Risk factor changes and mortality results. Journal of the American Medical Association 248, 1465-1477.
14. Piantadosi, S. (1997). Clinical Trials: A Methodologic Perspective. New York: Wiley.
15. Radhakrishna, S. (1965). Combination of results from several 2 × 2 contingency tables. Biometrics 21, 86-98.
16. Rao, C. R. (1973). Linear Statistical Inference and Its Application, 2nd edition. New York: Wiley.
17. Robins, J. M. and Greenland, S. (1994). Adjusting for differential rates of PCP prophylaxis in high- versus low-dose AZT treatment arms in an AIDS randomized trial. Journal of the American Statistical Association 89, 737-749.
18. Robins, J. M. and Tsiatis, A. A. (1991). Correcting for non-compliance in randomized trials using rank preserving structural failure time models. Communications in Statistics - Theory and Methods 20, 2609-2631.
19. Rothman, K. J. and Boice, J. D. (1979). Epidemiologic Analysis with a Programmable Calculator. NIH Publication. 79-1649. Washington, DC: U.S. Government Printing Office.
20. Sato, T. (1994). Randomized intent-to-analyses. Japanese Journal of Applied Statistics 23, 21-34 (in Japanese).
21. Sato, T. (2000). Sample size calculations with compliance information. Statistics in Medicine 19, 2689-2697.
22. Schwartz, D. and Lellouch, J. (1967). Explanatory and pragmatic attitudes in therapeutic trials. Journal of Chronic Diseases 20, 637-648.
23. Sheiner, L. and Rubin, D. B. (1995). Intention-to-treat analysis and the goals of clinical trials. Clinical Pharmacology and Therapeutics 87, 6-15.